|
Quotes & Info
|
| ABIO > SEC Filings for ABIO > Form 8-K on 12-Dec-2012 | All Recent SEC Filings |
12-Dec-2012
Other Events, Financial Statements and Exhibits
On December 12, 2012, ARCA biopharma, Inc. announced that the paper "Effect of Bucindolol (Gencaro) on Heart Failure Outcomes and Heart Rate Response in Patients with Reduced Ejection Fraction Heart Failure and Atrial Fibrillation" was published in the European Journal of Heart Failure (www.escardio.org/journals/european-journal-heart-failure), a publication of the Heart Failure Association of the European Society of Cardiology. The press release is furnished as Exhibit 99.1 hereto, the contents of which are incorporated herein by reference.
(d) Exhibits.
Exhibit
Number Description
99.1 Press Release titled "Gencaro™ Cardiovascular Effect On Patients With
Atrial Fibrillation Paper Published In European Journal Of Heart
Failure" dated December 12, 2012.
|
|
|